COVID-19 vaccine safety during the antenatal period in women with idiopathic inflammatory myopathies
Standard
COVID-19 vaccine safety during the antenatal period in women with idiopathic inflammatory myopathies. / Andreoli, Laura; Sen, Parikshit; Lini, Daniele; Vincze, Melinda Nagy; Schreiber, Karen; Agarwal, Vikas; Aggarwal, Rohit; Gupta, Latika; COVAD Study Group.
in: RHEUMATOLOGY, Jahrgang 62, Nr. 6, 01.06.2023, S. e175-e179.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › Letter › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - COVID-19 vaccine safety during the antenatal period in women with idiopathic inflammatory myopathies
AU - Andreoli, Laura
AU - Sen, Parikshit
AU - Lini, Daniele
AU - Vincze, Melinda Nagy
AU - Schreiber, Karen
AU - Agarwal, Vikas
AU - Aggarwal, Rohit
AU - Gupta, Latika
AU - COVAD Study Group
AU - Holzer, Marie-Therese
PY - 2023/6/1
Y1 - 2023/6/1
KW - Pregnancy
KW - Female
KW - Humans
KW - COVID-19 Vaccines/adverse effects
KW - COVID-19/prevention & control
KW - Myositis/chemically induced
U2 - 10.1093/rheumatology/keac644
DO - 10.1093/rheumatology/keac644
M3 - Letter
C2 - 36370070
VL - 62
SP - e175-e179
JO - RHEUMATOLOGY
JF - RHEUMATOLOGY
SN - 1462-0324
IS - 6
ER -